Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Carbonic anhydrase related protein expression in astrocytomas and oligodendroglial tumors.

Karjalainen SL, Haapasalo HK, Aspatwar A, Barker H, Parkkila S, Haapasalo JA.

BMC Cancer. 2018 May 23;18(1):584. doi: 10.1186/s12885-018-4493-4.

2.

Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.

Mäkelä KS, Haapasalo JA, Ilvesaro JM, Parkkila S, Paavonen T, Haapasalo HK.

Histol Histopathol. 2014 Sep;29(9):1161-8. doi: 10.14670/HH-29.1161. Epub 2014 Mar 6.

PMID:
24599602
3.

Peroxiredoxins and their expression in ependymomas.

Haapasalo T, Nordfors K, Järvelä S, Kok E, Sallinen P, Kinnula VL, Haapasalo HK, Soini Y.

J Clin Pathol. 2013 Jan;66(1):12-7. doi: 10.1136/jclinpath-2012-201048. Epub 2012 Oct 16.

PMID:
23076395
4.

Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.

Koskinen MJ, Kautio AL, Haanpää ML, Haapasalo HK, Kellokumpu-Lehtinen PL, Saarto T, Hietaharju AJ.

Anticancer Res. 2011 Dec;31(12):4413-6.

PMID:
22199308
5.

Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.

Häyry V, Tynninen O, Haapasalo HK, Wölfer J, Paulus W, Hasselblatt M, Sariola H, Paetau A, Sarna S, Niemelä M, Wartiovaara K, Nupponen NN.

Neuropathol Appl Neurobiol. 2008 Oct;34(5):555-63. doi: 10.1111/j.1365-2990.2008.00949.x. Epub 2008 Mar 10.

PMID:
18346113
6.

Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.

Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastoreková S, Pastorek J, Parkkila SM, Haapasalo HK.

Clin Cancer Res. 2006 Jan 15;12(2):473-7.

7.

Low expression of p27 indicates a poor prognosis in patients with high-grade astrocytomas.

Kirla RM, Haapasalo HK, Kalimo H, Salminen EK.

Cancer. 2003 Feb 1;97(3):644-8.

8.

Inactivation of local root canal medicaments by dentine: an in vitro study.

Haapasalo HK, Sirén EK, Waltimo TM, Ørstavik D, Haapasalo MP.

Int Endod J. 2000 Mar;33(2):126-31.

PMID:
11307453
9.

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helén PT, Schraml P, Kallioniemi OP, Kononen J.

Cancer Res. 2000 Dec 1;60(23):6617-22.

10.

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis. Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes.

Sallinen PK, Sallinen SL, Helén PT, Rantala IS, Rautiainen E, Helin HJ, Kalimo H, Haapasalo HK.

Neuropathol Appl Neurobiol. 2000 Aug;26(4):319-31.

PMID:
10931365
11.

Primary malignant melanoma of the urinary bladder associated with widespread metastases.

Tainio HM, Kylmälä TM, Haapasalo HK.

Scand J Urol Nephrol. 1999 Dec;33(6):406-7.

PMID:
10636582
12.

Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis.

Sallinen SL, Sallinen PK, Kononen JT, Syrjäkoski KM, Nupponen NN, Rantala IS, Helén PT, Helin HJ, Haapasalo HK.

J Pathol. 1999 Jul;188(3):289-93.

PMID:
10419598
13.

Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

Liukkonen TJ, Lipponen PK, Helle M, Haapasalo HK, Nordling S, Rajala P.

Urol Res. 1996;24(1):61-6.

PMID:
8966844
14.
15.

Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.

Sallinen PK, Haapasalo HK, Visakorpi T, Helén PT, Rantala IS, Isola JJ, Helin HJ.

J Pathol. 1994 Dec;174(4):275-82.

PMID:
7884589
16.

Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms.

Haapasalo HK, Sallinen PK, Helén PT, Rantala IS, Helin HJ, Isola JJ.

J Pathol. 1993 Nov;171(3):207-14.

PMID:
7903983

Supplemental Content

Loading ...
Support Center